Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 4
2006 1
2007 1
2008 1
2009 1
2013 1
2014 1
2015 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Familial methionine malabsorption"
Page 1
Methyl nutrients, DNA methylation, and cardiovascular disease.
Glier MB, Green TJ, Devlin AM. Glier MB, et al. Mol Nutr Food Res. 2014 Jan;58(1):172-82. doi: 10.1002/mnfr.201200636. Epub 2013 May 10. Mol Nutr Food Res. 2014. PMID: 23661599 Review.
These methyl nutrients include vitamins (folate, riboflavin, vitamin B12, vitamin B6, choline) and amino acids (methionine, cysteine, serine, glycine). As such, imbalances in the metabolism of these nutrients have the potential to affect DNA methylation. ...
These methyl nutrients include vitamins (folate, riboflavin, vitamin B12, vitamin B6, choline) and amino acids (methionine, cysteine, …
Hyperhomocysteinemia in acute hepatic porphyria (AHP) and implications for treatment with givosiran.
Ventura P, Sardh E, Longo N, Balwani M, Plutzky J, Gouya L, Phillips J, Rhyee S, Fanelli MJ, Sweetser MT, Petrides PE. Ventura P, et al. Expert Rev Gastroenterol Hepatol. 2022 Sep;16(9):879-894. doi: 10.1080/17474124.2022.2110469. Epub 2022 Aug 25. Expert Rev Gastroenterol Hepatol. 2022. PMID: 35929959 Free article.
INTRODUCTION: Homocysteine is a sulfur-containing amino acid formed in the intermediary metabolism of methionine. Amino acid metabolism and heme biosynthesis pathways are complexly intertwined. Plasma homocysteine elevation, hyperhomocysteinemia (HHcy), has been reported i …
INTRODUCTION: Homocysteine is a sulfur-containing amino acid formed in the intermediary metabolism of methionine. Amino acid metaboli …
Characterization and review of MTHFD1 deficiency: four new patients, cellular delineation and response to folic and folinic acid treatment.
Burda P, Kuster A, Hjalmarson O, Suormala T, Bürer C, Lutz S, Roussey G, Christa L, Asin-Cayuela J, Kollberg G, Andersson BA, Watkins D, Rosenblatt DS, Fowler B, Holme E, Froese DS, Baumgartner MR. Burda P, et al. J Inherit Metab Dis. 2015 Sep;38(5):863-72. doi: 10.1007/s10545-015-9810-3. Epub 2015 Jan 30. J Inherit Metab Dis. 2015. PMID: 25633902 Free article. Review.
We now describe four additional patients from two different families. The second patient presented with hyperhomocysteinemia, megaloblastic anaemia, HUS, microangiopathy and retinopathy; all except the retinopathy resolved after treatment with hydroxocobalamin, betaine and …
We now describe four additional patients from two different families. The second patient presented with hyperhomocysteinemia, megalob …
Evidence of choline depletion and reduced betaine and dimethylglycine with increased homocysteine in plasma of children with cystic fibrosis.
Innis SM, Hasman D. Innis SM, et al. J Nutr. 2006 Aug;136(8):2226-31. doi: 10.1093/jn/136.8.2226. J Nutr. 2006. PMID: 16857845 Free article. Clinical Trial.
Choline is the precursor of betaine, which donates methyl groups for remethylation of homocysteine to methionine and dimethylglycine. Previously, we have shown phospholipid malabsorption and increased plasma homocysteine in children with CF. ...Choline depletion and …
Choline is the precursor of betaine, which donates methyl groups for remethylation of homocysteine to methionine and dimethylglycine. …
Ischemic stroke and hyperhomocysteinemia: truth or myth?
Terwecoren A, Steen E, Benoit D, Boon P, Hemelsoet D. Terwecoren A, et al. Acta Neurol Belg. 2009 Sep;109(3):181-8. Acta Neurol Belg. 2009. PMID: 19902811 Review.
Hyperhomocysteinemia is generally acknowledged as a treatable risk factor for atherotrombotic diseases, but a causal relationship between both is not yet definitively established. Hyperhomocysteinemia originates from a deviation in the methionine-homocysteine metabolism in …
Hyperhomocysteinemia is generally acknowledged as a treatable risk factor for atherotrombotic diseases, but a causal relationship between bo …
Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.
Stehouwer DA. Stehouwer DA. Drugs Aging. 2000 Apr;16(4):251-60. doi: 10.2165/00002512-200016040-00001. Drugs Aging. 2000. PMID: 10874520 Review.
High fasting plasma homocysteine levels (> 12 to 15 mumol/L) are commonly encountered in clinical practice and are associated with increased risk of atherothrombotic disease. ...There is reasonable, but not clearly definitive, evidence that high plasma homocysteine leve …
High fasting plasma homocysteine levels (> 12 to 15 mumol/L) are commonly encountered in clinical practice and are associated with …
Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
Booth GL, Wang EE. Booth GL, et al. CMAJ. 2000 Jul 11;163(1):21-9. CMAJ. 2000. PMID: 10920726 Free PMC article.
BENEFITS, HARMS AND COSTS: Cardiovascular disease is the leading cause of death in Canada. Homocysteine, generated in the metabolism of methionine, may have a role in the development of cardiovascular disease. ...Definitive guidelines for the management of hyperhomocystein …
BENEFITS, HARMS AND COSTS: Cardiovascular disease is the leading cause of death in Canada. Homocysteine, generated in the metabolism of m …
Genetic and lifestyle factors related to the periconception vitamin B12 status and congenital heart defects: a Dutch case-control study.
Verkleij-Hagoort AC, van Driel LM, Lindemans J, Isaacs A, Steegers EA, Helbing WA, Uitterlinden AG, Steegers-Theunissen RP. Verkleij-Hagoort AC, et al. Mol Genet Metab. 2008 May;94(1):112-9. doi: 10.1016/j.ymgme.2007.12.002. Epub 2008 Jan 15. Mol Genet Metab. 2008. PMID: 18226574
A low periconception vitamin B12 status is determined by genetic and lifestyle factors and causes hyperhomocysteinemia. We investigated methionine synthase reductase (MTRR) and transcobalamin II (TC) genes and maternal intake and serum concentrations of vitamin B12 in asso …
A low periconception vitamin B12 status is determined by genetic and lifestyle factors and causes hyperhomocysteinemia. We investigated m …
Relationship between thrombophilic disorders and type of severe early-onset hypertensive disorder of pregnancy.
Ganzevoort W, Rep A, De Vries JI, Bonsel GJ, Wolf H; PETRA-Investigators. Ganzevoort W, et al. Hypertens Pregnancy. 2007;26(4):433-45. doi: 10.1080/10641950701521601. Hypertens Pregnancy. 2007. PMID: 18066962 Clinical Trial.
SETTING: Two university hospitals in Amsterdam, the Netherlands. POPULATION: 216 patients participating in a randomized clinical trial with severe and early-onset hypertensive disorders of pregnancy. ...Univariate and multinomial regression analyses examined …
SETTING: Two university hospitals in Amsterdam, the Netherlands. POPULATION: 216 patients participating in a randomized clinical …
Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.
Vermeulen EG, Stehouwer CD, Twisk JW, van den Berg M, de Jong SC, Mackaay AJ, van Campen CM, Visser FC, Jakobs CA, Bulterjis EJ, Rauwerda JA. Vermeulen EG, et al. Lancet. 2000 Feb 12;355(9203):517-22. doi: 10.1016/s0140-6736(99)07391-2. Lancet. 2000. PMID: 10683000 Clinical Trial.
We investigated the effects of homocysteine-lowering treatment (folic acid plus vitamin B6) on markers of subclinical atherosclerosis among healthy siblings of patients with premature atherothrombotic disease. METHODS: We did a randomised, placebo-controlled trial a …
We investigated the effects of homocysteine-lowering treatment (folic acid plus vitamin B6) on markers of subclinical atherosclerosis among …
11 results